Ignite Creation Date:
2025-12-24 @ 4:49 PM
Ignite Modification Date:
2025-12-26 @ 5:15 PM
Study NCT ID:
NCT05172050
Status:
COMPLETED
Last Update Posted:
2023-12-26
First Post:
2021-12-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.
Sponsor:
Dompé Farmaceutici S.p.A
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RLX0120
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None